In reply
Maria Puopolo DStat, Anna Ladogana MD,
Vito Vetrugno PhD,
Maurizio Pocchiari MD,
Anna Ladogana MD
Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy
Search for more papers by this authorVito Vetrugno PhD
Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy
Search for more papers by this authorMaurizio Pocchiari MD
Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy
Search for more papers by this authorMaria Puopolo DStat, Anna Ladogana MD,
Vito Vetrugno PhD,
Maurizio Pocchiari MD,
Anna Ladogana MD
Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy
Search for more papers by this authorVito Vetrugno PhD
Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy
Search for more papers by this authorMaurizio Pocchiari MD
Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy
Search for more papers by this authorNo abstract is available for this article.
REFERENCES
- 1 Molesworth AM, Mackenzie J, Everington D, Knight RSG, Will RG. Sporadic Creutzfeldt-Jakob disease and risk of blood transfusion in the United Kingdom. Transfusion 2011; 51: 1872-3.
- 2 Puopolo M, Ladogana A, Vetrugno V, Pocchiari M. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Transfusion 2011; 51: 1556-66.
- 3 Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999; 353: 693-97.
- 4 Zerr I, Brandel JP, Masullo C, Wientjens D, de Silva R, Zeidler M, Zeidler M, Granieri E, Sampaolo S, van Duijn C, Delasnerie-Lauprêtre N, Will R, Poser S. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol 2000; 53: 747-54.
- 5 Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Yamada M. Medical procedures and risk for sporadic Creutzfeldt-Jakob disease, Japan, 1999-2008. Emerg Infect Dis 2009; 15: 265-71.
- 6 Taubes G. Epidemiology faces its limits. Science 1995; 269: 164-9.
- 7 Cole P. Causality in epidemiology, health policy, and law. Environ Law Rep 1997; 27: 10279-85.
- 8 Dorsey K, Zou S, Schonberger LB, Sullivan M, Kessler D, Notari EIV, Fang CT, Dodd RY. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion 2009; 49: 977-84.
- 9 Hewitt PE, Llewelyn CA, MacKenzie J, Will RG. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 2006; 91: 221-30.
Citing Literature
